Thanks for the post @onesurfed. Paxalisib having a median PFS of 9.6 months for the dose used in GBM Agile sounds very promising.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
